150 related articles for article (PubMed ID: 37266563)
21. Precision Medicine and Pancreatic Cancer.
George B
Surg Oncol Clin N Am; 2021 Oct; 30(4):693-708. PubMed ID: 34511190
[TBL] [Abstract][Full Text] [Related]
22. Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.
Lee CL; Holter S; Borgida A; Dodd A; Ramotar S; Grant R; Wasson K; Elimova E; Jang RW; Moore M; Kim TK; Khalili K; Moulton CA; Gallinger S; O'Kane GM; Knox JJ
World J Gastroenterol; 2022 Dec; 28(45):6421-6432. PubMed ID: 36533108
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
Chandana S; Babiker HM; Mahadevan D
Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
[TBL] [Abstract][Full Text] [Related]
26. Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease.
Murphy SJ; Hart SN; Halling GC; Johnson SH; Smadbeck JB; Drucker T; Lima JF; Rohakhtar FR; Harris FR; Kosari F; Subramanian S; Petersen GM; Wiltshire TD; Kipp BR; Truty MJ; McWilliams RR; Couch FJ; Vasmatzis G
Cancer Res; 2016 Feb; 76(3):749-61. PubMed ID: 26676757
[TBL] [Abstract][Full Text] [Related]
27. Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report.
Ohara Y; Oda T; Enomoto T; Hisakura K; Akashi Y; Ogawa K; Owada Y; Domoto Y; Miyazaki Y; Shimomura O; Kurata M; Ohkohchi N
World J Surg Oncol; 2018 Aug; 16(1):158. PubMed ID: 30075727
[TBL] [Abstract][Full Text] [Related]
28. Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group.
Petrova E; Wellner J; Nording AK; Braun R; Honselmann KC; Bolm L; Hummel R; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Timme-Bronsert S; Bronsert P; Zemskov S; Keck T; Wellner UF
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885230
[TBL] [Abstract][Full Text] [Related]
29. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR
Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745
[TBL] [Abstract][Full Text] [Related]
30. Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.
Connor AA; Denroche RE; Jang GH; Timms L; Kalimuthu SN; Selander I; McPherson T; Wilson GW; Chan-Seng-Yue MA; Borozan I; Ferretti V; Grant RC; Lungu IM; Costello E; Greenhalf W; Palmer D; Ghaneh P; Neoptolemos JP; Buchler M; Petersen G; Thayer S; Hollingsworth MA; Sherker A; Durocher D; Dhani N; Hedley D; Serra S; Pollett A; Roehrl MHA; Bavi P; Bartlett JMS; Cleary S; Wilson JM; Alexandrov LB; Moore M; Wouters BG; McPherson JD; Notta F; Stein LD; Gallinger S
JAMA Oncol; 2017 Jun; 3(6):774-783. PubMed ID: 27768182
[TBL] [Abstract][Full Text] [Related]
31. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
;
Cancer Cell; 2017 Aug; 32(2):185-203.e13. PubMed ID: 28810144
[TBL] [Abstract][Full Text] [Related]
32. Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples.
Semaan A; Bernard V; Lee JJ; Wong JW; Huang J; Swartzlander DB; Stephens BM; Monberg ME; Weston BR; Bhutani MS; Chang K; Scheet PA; Maitra A; Jakubek YA; Guerrero PA
Clin Cancer Res; 2021 Feb; 27(4):1082-1093. PubMed ID: 33188144
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
[TBL] [Abstract][Full Text] [Related]
34. BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation.
Ghosh T; Greipp PT; Knutson D; Kloft-Nelson S; Jenkins S; Mounajjed T; Said S; La Rosa S; Vanoli A; Sessa F; Naini BV; Bellizzi A; Zhang L; Kerr SE; Graham RP
Arch Pathol Lab Med; 2022 Jul; 146(7):840-845. PubMed ID: 34614142
[TBL] [Abstract][Full Text] [Related]
35. Pathology and genetics of pancreatic neoplasms with acinar differentiation.
Wood LD; Klimstra DS
Semin Diagn Pathol; 2014 Nov; 31(6):491-497. PubMed ID: 25441307
[TBL] [Abstract][Full Text] [Related]
36. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.
Furukawa T; Sakamoto H; Takeuchi S; Ameri M; Kuboki Y; Yamamoto T; Hatori T; Yamamoto M; Sugiyama M; Ohike N; Yamaguchi H; Shimizu M; Shibata N; Shimizu K; Shiratori K
Sci Rep; 2015 Mar; 5():8829. PubMed ID: 25743105
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer.
Zhang X; Mao T; Zhang B; Xu H; Cui J; Jiao F; Chen D; Wang Y; Hu J; Xia Q; Ge W; Li S; Yue M; Ma J; Yao J; Wang Y; Wang Y; Shentu D; Zhang X; Chen S; Bai Y; Wang Y; Zhang X; Liu Q; Sun Y; Fu D; Liu Y; Xiong L; Wang L
EBioMedicine; 2022 Mar; 77():103897. PubMed ID: 35231699
[TBL] [Abstract][Full Text] [Related]
38. RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas.
Chou A; Brown IS; Kumarasinghe MP; Perren A; Riley D; Kim Y; Pajic M; Steinmann A; Rathi V; Jamieson NB; Verheij J; van Roessel S; Nahm CB; Mittal A; Samra J; Gill AJ
Mod Pathol; 2020 Apr; 33(4):657-664. PubMed ID: 31558784
[TBL] [Abstract][Full Text] [Related]
39. [Pancreatic acinar neoplasms : Comparative molecular characterization].
Bergmann F
Pathologe; 2016 Nov; 37(Suppl 2):191-195. PubMed ID: 27807633
[TBL] [Abstract][Full Text] [Related]
40. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
